Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-297818

General Counsel sold 245 shares at $29.98 ($7,345)

  • General Counsel acquired 680 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Winslow Garrett · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-03 Exercise or conversion : show line 1 in the form +680 2,534 D
2026-07-06 Sale : show line 2 in the form −245 $29.98 $7,345 2,289 D
Open-market sales · 245 sh · avg $29.98 · $7,345

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −680 640 D
Loading xslF345X06/ownership.xml…